newsfilter
← Latest News
GlobeNewswire·

Decibel Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Update

- Bolstered Board of Directors and Scientific Advisory Board with key appointments - - On track for anticipated 2022 milestones including submission of IND and/or CTA for DB-OTO and interim analysis of DB-020 Phase 1b trial for cisplatin-induced h